Industry wants new European pharma makeover to increase the continent's attractiveness for R&D
Later this year, the European Commission is planning to release a major proposal to overhaul the continent’s general pharmaceutical legislation, as part of plans to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.